Castration Resistant Prostate Cancer, An Issue of Urologic Clinics
Adam Kibel, MD, Brigham and Women's Hospital
Castrate Resistant Prostate Cancer is advanced disease that has stopped responding to hormone therapy. This issue of the Urologic Clinics focuses on the various forms of therapy including immunotherapy, first line chemotherapy, and novel targeted agents. Articles on defining the diseae and palliative care are also included.